EdgeScore

ALXO · Nasdaq

ALX ONCOLOGY HOLDINGS INC: financial statements

Financially weak · see the checkFigures in USD, fiscal years

Revenue and net income

Revenue 2019: $4.8MNet income 2019: -$19.2M2019Revenue 2020: $1.2MNet income 2020: -$45.7M2020Revenue 2021: $0Net income 2021: -$83.5M2021Revenue 2022: $0Net income 2022: -$123M2022
RevenueNet income

Operating and free cash flow

Operating cash flow 2019: -$14.2MFree cash flow 2019: -$14.6M2019Operating cash flow 2020: -$38.3MFree cash flow 2020: -$38.3M2020Operating cash flow 2021: -$68.1MFree cash flow 2021: -$68.8M2021Operating cash flow 2022: -$89.2MFree cash flow 2022: -$90.7M2022
Operating cash flowFree cash flow

Margins

Operating 2019: -400.0%Operating 2020: -3694.0%Net 2019: -401.2%Net 2020: -3869.7%2019202020212022
GrossOperatingNet

Returns

ROE 2020: -10.6%ROE 2021: -23.0%ROE 2022: -46.9%ROIC 2022: -89.6%ROA 2019: -180.2%ROA 2020: -10.5%ROA 2021: -22.0%ROA 2022: -40.3%2019202020212022
ROEROICROA

Income statement

USD2019202020212022Last year
Revenue$4.8M$1.2M$0$0
Operating income-$19.2M-$43.7M-$83.6M-$127M-53%
EBITDA-$18.8M-$43.5M-$83.5M-$127M-52%
Interest expense—$427K$13.0K$238K+1731%
Profit before tax-$19.2M-$45.5M-$83.5M-$123M-48%
Income tax$34.0K$241K-$21.0K$64.0K+405%
Net income-$19.2M-$45.7M-$83.5M-$123M-48%

Cash flow

USD2019202020212022Last year
Operating cash flow-$14.2M-$38.3M-$68.1M-$89.2M-31%
Capital expenditure$353K$31.0K$666K$1.4M+114%
Free cash flow-$14.6M-$38.3M-$68.8M-$90.7M-32%
Depreciation & amortization$429K$202K$51.0K$342K+571%

Balance sheet

USD2019202020212022Last year
Cash$9.0M$434M$364M$48.8M-87%
Current assets$9.8M$436M$367M$271M-26%
Total assets$10.7M$436M$380M$306M-19%
Current liabilities$5.0M$6.2M$15.3M$28.3M+85%
Financial debt$5.4M——$10.6M
Total liabilities$11.0M$6.2M$17.1M$43.0M+151%
Shareholders' equity-$70.6M$430M$363M$263M-27%
Net debt-$3.6M-$434M-$364M-$38.2M+89%

Ratios

2019202020212022Last year
Operating margin-400.0%-3694.0%——
Net margin-401.2%-3869.7%——
Return on equity—-10.6%-23.0%-46.9%
Return on assets-180.2%-10.5%-22.0%-40.3%
Return on invested capital———-89.6%
Debt / equity———0.04
Interest coverage—-102.3x-6427.3x-535.4x
Current ratio1.9770.2824.009.57
Quick ratio1.9770.2824.009.57

Data source: SEC EDGAR, company annual reports. Lines a company does not report are left empty. Free cash flow is operating cash flow minus capital expenditure. Ratios use the same formulas as the EdgeScore check.

For information and education only. Not investment advice. Data may contain errors.